Slovakia

ZIOPHARM Treats Patients in US Phase I Trials of Oral Darinaparsin ...
Business Wire (press release) - San Francisco,CA,USA
Darinaparsin is a proprietary, small-molecule organic arsenic licensed
exclusively to ZIOPHARM from The University of Texas MD Anderson Cancer
Center and ...
<http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070910005530&newsLang=en>
See all stories on this topic:
<http://news.google.com/news?hl=en&ncl=http://home.businesswire.com/portal/site/google/index.jsp%3FndmViewId%3Dnews_view%26newsId%3D20070910005530%26newsLang%3Den>

This as-it-happens Google Alert is brought to you by Google...
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Remove this Google Alert:
http://www.google.com/alerts/remove?s=EAAAAJeSJKIMkv4rU2v-o3jjRUY&hl=en

Create another Google Alert:
http://www.google.com/alerts?hl=en

Sign in to manage your alerts:
http://www.google.com/alerts/manage?hl=en